Rapid Quantification of Efavirenz in Human Plasma by Electrospray Ionization Tandem Mass Spectrometry

被引:3
作者
Kailasa, Suresh Kumar [1 ,2 ,3 ]
Wu, Hui-Fen [1 ,2 ,4 ,5 ,6 ]
机构
[1] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan
[2] Natl Sun Yat Sen Univ, Ctr Nanosci & Nanotechnol, Kaohsiung 80424, Taiwan
[3] SV Natl Inst Technol, Dept Chem, Surat 395007, India
[4] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan
[5] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung 806, Taiwan
[6] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 80424, Taiwan
关键词
Efavirenz; Human plasma; ESI-MS; PERFORMANCE LIQUID-CHROMATOGRAPHY; ANTI-HIV DRUGS; ANTIRETROVIRAL THERAPY; AFFINITY PROBES; RITONAVIR; LOPINAVIR; INFECTION; INDINAVIR; MATRIX; AMPRENAVIR;
D O I
10.1002/jccs.201300359
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We report a rapid and sensitive method for detecting efavirenz in human plasma by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Detection of efavirenz in human plasma samples was confirmed by acquiring MS/MS of protonated efavirenz at m/z 316.5 to yield the characteristic fragment ions at m/z 298, 274, 272, 251, 246, 237, 232, 203 and 168, respectively. This approach provided good linearity for the quantification of efavirenz (R-2 = approximate to 0.9989), with good precision (RSD >10%) and limit of detection (0.20 nM). This method can be widely applied for precise quantitative analysis of a variety of drugs in clinical samples.
引用
收藏
页码:437 / 441
页数:5
相关论文
共 32 条
[1]   Therapeutic drug monitoring - An aid to optimising response to antiretroviral drugs? [J].
Aarnoutse, RE ;
Schapiro, JM ;
Boucher, CAB ;
Hekster, YA ;
Burger, DM .
DRUGS, 2003, 63 (08) :741-753
[2]  
[Anonymous], 1998, MORTAL WKLY REF, V47, pRR
[3]  
Bartlett J, 2007, MED MANAGEMENT HIV I
[4]   Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [J].
Cavert, W ;
Notermans, DW ;
Staskus, K ;
Wietgrefe, SW ;
Zupancic, M ;
Gebhard, K ;
Henry, K ;
Zhang, ZQ ;
Mills, R ;
McDade, H ;
Goudsmit, J ;
Danner, SA ;
Haase, AT .
SCIENCE, 1997, 276 (5314) :960-964
[5]   Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction [J].
Colombo, S ;
Guignard, N ;
Marzolini, C ;
Telenti, A ;
Biollaz, J ;
Decosterd, LA .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 810 (01) :25-34
[6]   Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection [J].
Dailly, E ;
Raffi, F ;
Jolliet, P .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 813 (1-2) :353-358
[7]   Universal Voluntary Testing and Treatment for Prevention of HIV Transmission [J].
Dieffenbach, Carl W. ;
Fauci, Anthony S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (22) :2380-2382
[8]   Voltammetric studies on the HIV-1 inhibitory drug Efavirenz: The interaction between dsDNA and drug using electrochemical DNA biosensor and adsorptive stripping voltammetric determination on disposable pencil graphite electrode [J].
Dogan-Topal, Burcu ;
Uslu, Bengi ;
Ozkan, Sibel A. .
BIOSENSORS & BIOELECTRONICS, 2009, 24 (08) :2358-2364
[9]   Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography [J].
Droste, JAH ;
Verweij-van Wissen, CPWGM ;
Burger, DM .
THERAPEUTIC DRUG MONITORING, 2003, 25 (03) :393-399
[10]   Determination of lamivudine/stavudine/efavirenz in human serum using liquid chromatography/electrospray tandem mass spectrometry with ionization polarity switch [J].
Fan, B ;
Bartlett, MG ;
Stewart, JT .
BIOMEDICAL CHROMATOGRAPHY, 2002, 16 (06) :383-389